Section Arrow
Quote
CYTO.NASDAQ
- Altamira Therapeutics Ltd
Quotes are at least 15-min delayed:2024/05/16 01:37 EDT
Last
 1.53
+0.09 (+6.25%)
Day High 
1.5699 
Prev. Close
1.44 
1-M High
1.88 
Volume 
55.13K 
Bid
1.44
Ask
1.56
Day Low
1.4301 
Open
1.5225 
1-M Low
1.35 
Market Cap 
3.23M 
Currency USD 
P/E -- 
%Yield 0 
10-SMA 1.54 
20-SMA 1.53 
50-SMA 1.76 
52-W High 23.6 
52-W Low 1.35 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-7.88/-2.11
Enterprise Value
3.23M
Balance Sheet
Book Value Per Share
3.18
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.06
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8391-0.0237-2.75%-- 
NVAXNovavax12.9-0.58-4.30%-- 
JAGXJaguar Health0.2551-0.0198-7.20%-- 
OCGNOcugen1.96+0.26+15.29%-- 
ARQTArcutis Biotherapeutics9.24+1.11+13.65%-- 
Quotes are at least 15-min delayed：2024/05/16 01:37 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray forpersonal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation.This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.